Atabecestat
Atabecestat (JNJ-54861911) is a potent, brain-penetrant, and orally active β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor that achieves robust and high CSF Aβ reduction, is well-tolerated, and displays sustained pharmacokinetic (PK) and pharmacodynamic (PD) characteristics. Atabecestat (JNJ-54861911) has the potential for Alzheimer's Disease treatment.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
367.4
Molecular Formula
C18H14FN5OS
Notes
Research use only, not for human use.
Receptor
BACE
CAS Number
1200493-78-2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
47947141 1x10<sup>6</sup> cells/1.0ml
TRNAC32P CRISPR Knock Out 293T Cell Line (Human)
Ask
View Details 
MBS6274970-01 0.1 mL
ARHGEF16, NT (ARHGEF16, EPHEXIN4, NBR, Rho guanine nucleotide exchange factor 16, Ephexin-4) (MaxLight 650)
Ask
View Details MBS6274970-02 5x 0.1 mL
ARHGEF16, NT (ARHGEF16, EPHEXIN4, NBR, Rho guanine nucleotide exchange factor 16, Ephexin-4) (MaxLight 650)
Ask
View Details 